Published in Circ Res on February 03, 2017
Limb-shaking TIA: on the borders of evidence-based medicine. Intern Emerg Med (2017) 0.75
A High-Resolution MRI Study of Relationship between Remodeling Patterns and Ischemic Stroke in Patients with Atherosclerotic Middle Cerebral Artery Stenosis. Front Aging Neurosci (2017) 0.75
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet (2001) 17.97
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76
Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med (2012) 8.39
Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92
A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med (2001) 7.07
Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet (2007) 6.29
Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med (1985) 5.53
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet (2013) 4.57
A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol (2000) 4.29
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21
Physical activity and stroke risk: a meta-analysis. Stroke (2003) 4.19
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology (2008) 3.77
A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol (2007) 3.56
Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol (2004) 3.37
Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2004) 3.34
The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology (2007) 3.24
US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke (2007) 3.17
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol (2010) 2.97
A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke (2007) 2.70
Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke (2008) 2.68
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62
Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation (2007) 2.50
Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation (2000) 2.38
Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke (2004) 2.38
Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology (2012) 2.19
The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology (1995) 2.10
Race, sex and occlusive cerebrovascular disease: a review. Stroke (1986) 2.05
Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg (2012) 2.03
Virtual histology intravascular ultrasound assessment of carotid artery disease: the Carotid Artery Plaque Virtual Histology Evaluation (CAPITAL) study. J Endovasc Ther (2007) 1.98
Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology (2007) 1.97
Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke (2006) 1.83
Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology (1990) 1.82
Specific DWI lesion patterns predict prognosis after acute ischaemic stroke within the MCA territory. J Neurol Neurosurg Psychiatry (2005) 1.81
Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg (1993) 1.81
Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke (2005) 1.81
Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology (2003) 1.81
Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol (2007) 1.79
Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol (1997) 1.75
Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol (2002) 1.64
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial. Circ Cardiovasc Qual Outcomes (2012) 1.63
Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. Proc Staff Meet Mayo Clin (1955) 1.58
Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis. Hypertension (2011) 1.54
Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysis. Stroke (2012) 1.47
Effect of Hemodynamics on Stroke Risk in Symptomatic Atherosclerotic Vertebrobasilar Occlusive Disease. JAMA Neurol (2016) 1.47
Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg (1999) 1.46
Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial. J Neurointerv Surg (2012) 1.45
Severity assessment of intracranial large artery stenosis by pressure gradient measurements: A feasibility study. Catheter Cardiovasc Interv (2016) 1.40
Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke (2008) 1.36
Impact of body mass index on incident hypertension and diabetes in Chinese Asians, American Whites, and American Blacks: the People's Republic of China Study and the Atherosclerosis Risk in Communities Study. Am J Epidemiol (2008) 1.31
Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study. Neurosurgery (2003) 1.31
Middle cerebral artery atherosclerosis: histological comparison between plaques associated with and not associated with infarct in a postmortem study. Cerebrovasc Dis (2007) 1.30
Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke (1995) 1.26
Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke (1999) 1.24
Risk factors and stroke mechanisms in atherosclerotic stroke: intracranial compared with extracranial and anterior compared with posterior circulation disease. Stroke (2012) 1.23
The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. J Am Coll Cardiol (2008) 1.20
Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol (2005) 1.20
Atherosclerotic disease of the middle cerebral artery. Stroke (1987) 1.18
Pattern of cerebral atherosclerosis in Hong Kong Chinese. Severity in intracranial and extracranial vessels. Stroke (1993) 1.15
Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology (2006) 1.13
Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke (2008) 1.11
Intracranial carotid artery atherosclerosis: prevalence and risk factors in the general population. Stroke (2012) 1.10
Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis. Arch Neurol (2000) 1.10
Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology (2007) 1.10
Vertebrobasilar Flow Evaluation and Risk of Transient Ischaemic Attack and Stroke study (VERiTAS): rationale and design. Int J Stroke (2010) 1.09
Collateral circulation in symptomatic intracranial atherosclerosis. J Cereb Blood Flow Metab (2010) 1.08
Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis. J Neuroimaging (2014) 1.08
Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese. Eur J Neurol (2005) 1.06
A door-to-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology (2007) 1.05
The role of indirect extracranial-intracranial bypass in the treatment of symptomatic intracranial atheroocclusive disease. J Neurosurg (2009) 1.04
Risk factors of intracranial cerebral atherosclerosis among asymptomatics. Cerebrovasc Dis (2007) 1.03
Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke (2011) 1.03
Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study. Neurosurgery (2012) 1.02
Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke (2004) 1.02
Complications of intracranial bypass for vertebrobasilar insufficiency. J Neurosurg (1989) 1.02
Intracranial vertebrobasilar stenosis: angioplasty and follow-up. AJNR Am J Neuroradiol (2000) 1.01
Angioplasty for intracranial artery stenosis. Cochrane Database Syst Rev (2006) 1.01
The prevalence of asymptomatic intracranial large-vessel occlusive disease: the role of diabetes. J Neuroimaging (2003) 0.98
Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke (2008) 0.97
Distribution of internal elastic lamina and external elastic lamina in the internal carotid artery: possible relationship with atherosclerosis. Neurol Med Chir (Tokyo) (2010) 0.97
Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery (2002) 0.97
Effects of statins on the progression of cerebral white matter lesion: Post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study. J Neurol (2009) 0.96
Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis. Stroke (2008) 0.96
Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study. Stroke (2012) 0.95
Design of the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) trial in symptomatic intracranial stenosis. J Stroke Cerebrovasc Dis (2012) 0.92
Racial differences in cerebrovascular disease. Angiographic evaluation of Japanese and American populations. Am J Roentgenol Radium Ther Nucl Med (1967) 0.91
Cerebral atherosclerosis in New Orleans. Comparisons of lesions by age, sex, and race. Lab Invest (1985) 0.91
Adiponectin levels in patients with intracranial atherosclerosis. Neurology (2007) 0.91
An explanation for variations in distribution of stroke and arteriosclerotic heart disease among populations and racial groups. Am J Epidemiol (1971) 0.91
Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats. Brain Res (2012) 0.90
Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial. JAMA Neurol (2016) 0.90
Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries. Circulation (1963) 0.89